Recursion Pharmaceuticals, Inc 10-K for FY2022
Recursion Pharmaceuticals, Inc. (RXRX)
10-K
2023-02-27
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
Recursion Pharmaceuticals, Inc filed this 10-K on February 27, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $39.84M
- up 291.5% from $10.18M a year earlier
- Net loss
- $239.48M
- compared with a net loss of $186.48M a year earlier
- Diluted EPS
- -$1.36
- compared with -$1.49 a year earlier